Introduction {#sec1}
============

For many years, the synthesis of N-heterocyclic compounds has been on the spotlight of different fields of science, especially on the organic synthesis and medicinal chemistry. The interest in the synthesis of these compounds is associated with the diversified biological activities found among the class of N-heterocycles.^[@ref1]^ Triazoles, for example, have been widely explored due to their interesting biological activities,^[@ref2],[@ref3]^ such as anticancer, anti-human immunodeficiency virus, antilieshmanial, antitrypanosomal, and antibiotic ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Biologically active triazole compounds.](ao-2018-02764b_0001){#fig1}

Since the pioneering work of Huisgen for the 1,3-dipolar cycloaddition reaction between azides and alkynes^[@ref4]^ in the 1960s, the synthesis of five-membered heterocycles (including triazolic cores) has been on the spotlight of N-heterocyclic chemistry. After this work, Sharpless and co-workers improved Huisgen's approach for the construction of triazole cores via an elegant methodology based on the copper-catalyzed azide--alkyne cycloadditions.^[@ref5],[@ref6]^ Since these contributions, the synthesis and biological evaluation of triazoles have been exponentially growing.^[@ref7]^ Known as "click reaction", this well-established methodology allows the synthesis of N1-, C4-, and/or C5-substituted triazolic cores in an intramolecular or intermolecular fashion.^[@ref8]^ Due to its versatility, the click reaction has been employed as one of the principal strategies for the construction of \[1,2,3\]-triazolic cores.

Despite the cycloaddition reaction between azides and alkynes described above, there are just few methodologies found in the literature for the synthesis of triazole compounds, particularly fused bicyclic \[1,2,3\]-triazoles.^[@ref9]^ An interesting approach for the bicyclic triazolic core construction was reported by Katritzky and co-workers.^[@ref10]^ In this work, an intramolecular reaction between an in situ generated diazonium salt and an azo group was performed, furnishing 1-aminobenzotriazole ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, chart A). Another approach was reported by Kascheres and co-workers^[@ref11]^ based on the employment of diazo-transfer reagents (such as 3-diazo-5,7-dinitroindolin-2-one) for the synthesis of fused bicyclic \[1,2,3\]-triazoles from cyclic amines ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, chart B). An alternative strategy was also applied in the synthesis of bicyclic \[1,2,3\]-triazoles employing the already constructed triazolic cores in sequential reactions that led to the formation of the second ring. Usually, the triazole unit is synthesized by the azide--alkyne cycloaddition reaction and the second ring formed from C--C coupling reactions.^[@ref12]−[@ref16]^ For example, in Fiandanese's strategy,^[@ref17]^ an intramolecular Heck reaction was the key step to construct the bicyclic unit ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, chart C).

![Selected Methodologies for the Synthesis of Bicyclic \[1,2,3\]-Triazoles](ao-2018-02764b_0002){#sch1}

Diazocompounds are versatile building blocks known for their application in the synthesis of different classes of heterocycles.^[@ref18]−[@ref20]^ Due to its versatility, we wondered if γ-*N*-protected diazoketones could be employed as advanced building blocks to construct these bicyclic triazole cores ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, chart D). Although a similar transformation was initially observed by Clark,^[@ref21]^ during the preparation of two substrates that would be applied in an ammonium ylide rearrangement, to the best of our knowledge, general methods that permit the synthesis of several bicyclic triazoles have not been explored. Herein, we describe the synthesis of bicyclic \[1,2,3\]-triazoles, containing two fused five-membered rings, from γ-*N*-(trifluoroacetyl) amino diazoketones. This was accomplished in a straightforward fashion that includes three sequential steps in a single reaction vessel: *N*-deprotection, intramolecular α-diazo imine formation, and 5-*endo*-dig cyclization ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, chart D).

Results and Discussion {#sec2}
======================

Aiming at the synthesis of γ-*N*-(trifluoroacetyl) amino diazoketones, we started our work with the preparation of γ-nitro ester precursors **2a**--**j** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Initially, we synthesized γ-nitro ester **2a** via a conjugate addition between the commercially available ethyl cinnamate and nitromethane to furnish **2a** in 84% yield. Since not all of the ethyl cinnamates are commercially available, we employed a Horner--Wadsworth--Emmons olefination for the generation of α,β-unsaturated esters, which were directly submitted to a conjugate addition with nitromethane. By this way, γ-nitro ester precursors were obtained in 50--70% yield after a two-step process, without the isolation of the respective α,β-unsaturated ester.

![Synthesis of γ-Nitro Esters](ao-2018-02764b_0003){#sch2}

The next step consisted of the synthesis of γ-*N*-(trifluoroacetyl) amino acids based on a protocol of nitro group reduction to amine, hydrolysis of the ester portion, and protection of the generated free amine ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Synthesis of γ-*N*-(Trifluoroacetyl) Amino Acids](ao-2018-02764b_0004){#sch3}

The change in the reducing power of sodium borohydrate by the combination with inorganic salts is a well-known method.^[@ref22]−[@ref25]^ For the reduction of the nitro group, we selected the classical method, which employs nickel chloride hexahydrate (NiCl~2~·6H~2~O) and sodium borohydrate (NaBH~4~) for the in situ generation of nickel borohydrate complex.^[@ref26]^ After the reduction, ester hydrolysis was carried out in refluxing aqueous solution of hydrochloric acid (HCl) to furnish γ-amino acids as hydrochloride salts.^[@ref27]^ Next, the final step consisted of the protection of the amino group as a trifluoroacetamide via a well-known protocol employing trifluoroacetic anhydride (TFAA) and triethylamine (Et~3~N) in methanol.^[@ref28]^ By the application of these protocols, we were able to perform these three steps without any purification of the intermediates. In this fashion, a series of γ-*N*-(trifluoroacetyl) amino acids **3a**--**j** could be synthesized in 40--83% yield after a three-step process ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

Once the synthesis of γ-*N*-(trifluoroacetyl) amino acids **3a**--**j** was secured, we turned our attention to the preparation of γ-*N*-(trifluoroacetyl) diazoketones. In this direction, we applied a well-established protocol for carboxylic acid activation and diazomethane acylation. Refluxing the corresponding γ-*N*-(trifluoroacetyl) amino acids with oxalyl chloride for 2.5 h activated the carboxylic acid function as an acyl chloride intermediate. In the following step, the freshly prepared acyl chloride was allowed to react with an ethereal solution of diazomethane.^[@ref29]^ Applying this sequence, γ-*N*-(trifluoroacetyl) diazoketones **4a**--**k** were prepared in 30--94% yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Synthesis of γ-*N*-(Trifluoroacetyl) Diazoketones](ao-2018-02764b_0005){#sch4}

We also tried to obtain more substituted γ-*N*-(trifluoroacetyl) diazoketones, aiming at the synthesis of more complex fused bicyclic \[1,2,3\]-triazoles. For this purpose, we followed the same protocol depicted in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"} for the activation of γ-*N*-(trifluoroacetyl) amino acid **3a**, although changing the diazomethane for an ethereal solution of diazoethane in the acylation step. Unfortunately, the reaction with diazoethane has shown only 20% yield for the formation of the substituted γ-*N*-(trifluoroacetyl) diazoketone **4k**. When we tried the same approach in other γ-*N*-(trifluroacetyl) amino acids, we only achieved traces of the substituted γ-*N*-(trifluoroacetyl) diazoketones.

The last step consisted of the construction of the fused bicyclic \[1,2,3\]-triazole cores from the synthesized γ-*N*-(trifluoroacetyl) diazoketones. It is worth mentioning that the synthesis of this class of fused bicyclic triazoles is less explored than other classes of triazoles. Usually, the main protocols for the synthesis of these compounds depend on the azide--alkyne cycloaddition approach via metal catalysis and normally use harsh experimental conditions (high temperatures and/or long reaction time).^[@ref30]−[@ref32]^ On the other hand, our strategy is based on a mild and direct process for the deprotection of the trifluoroacetamide group with subsequent cyclization to construct rings of the fused bicyclic triazoles.

Hence, deprotection was carried out in a simple protocol by gently refluxing the corresponding diazoketone with an aqueous solution of potassium carbonate (K~2~CO~3~). In this fashion, several fused bicyclic \[1,2,3\]-triazoles **5a**--**k** were synthesized in a straightforward process in good to excellent yields (63--95%) ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).

![Synthesis of the Fused Bicyclic \[1,2,3\]-Triazoles](ao-2018-02764b_0006){#sch5}

Considering the mechanism involved during the construction of the fused bicyclic \[1,2,3\]-triazoles, we believe that after the generation of free amine by the trifluoroacetamide hydrolysis, the formation of an α-diazo imine intermediate occurs ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Once this intermediate is formed, the next step consists of a 5-*endo*-dig cyclization by the nucleophilic attack of the imine to the terminal nitrogen of the diazo portion, leading to the bicyclic triazolic core.

![Proposed Mechanism for the Construction of the Fused Bicyclic \[1,2,3\]-Triazolic Core](ao-2018-02764b_0007){#sch6}

Conclusions {#sec3}
===========

In summary, we have described a straightforward method for the synthesis of fused bicyclic \[1,2,3\]-triazoles from γ-*N*-(trifluroacetyl) diazoketones. Different from protocols based on the Huisgen cycloaddition reaction, the employed strategy was based on the deprotection of a trifluoroacetamide group followed by the in situ generation of an α-diazo imine intermediate. From this key intermediate, we could prepare a series of fused bicyclic \[1,2,3\]-triazoles in 63--95% yields, via a 5-*endo*-dig cyclization step.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All of the reagents were purchased at highest quality and used without further purification. The solvents were previously dried based on protocols previously described in the literature. The reactions were monitored by thin-layer chromatography (charge coupled device) on 0.25 mm silica gel plates using UV light as visualization agent and KMnO~4~ in aqueous KOH solution for staining. The purifications were performed by chromatographic columns using Silica Gel 60 (particle size, 0.063--0.210 mm) unless otherwise stated. The reported yields refer to the products isolated after flash column chromatography. The proton nuclear magnetic resonance (^1^H NMR) acquisitions were performed in a 400 or 500 MHz equipment. The chemical shifts (δ) were referenced from the tetramethylsilane (0.00 ppm), and the coupling constants (*J*) are reported in hertz. The following multiplicities abbreviations were used in this report: bs, broad signal; s, singlet; d, doublet; t, triplet; q, quartet; quint, quintet; sext, sextet; sept, septet; dd, doublet of doublets; dt, doublet of triplets; dtd, doublet of triplet of doublets; ddd, doublet of doublet of doublets; dddd, doublet of doublet of doublet of doublets; td, triplet of doubles; dddt; doublet of doublet of doublet of triplets; tt, triplet of triples; tq, triplet of quartets; qd, quartet of doublets; septd, septet of doublets; and m, multiplet. The carbon nuclear magnetic resonance (^13^C NMR) acquisitions were performed in a 101 or 126 MHz equipment. The chemical shifts (δ) were referenced from CDCl~3~ (77.0 ppm) or CD~3~OD (49.0 ppm). The infrared spectra acquisitions were performed using an Fourier-transform infrared spectrometer of 4.0 cm^--1^ resolution and were reported in number of waves. The melting points were determined using a digital melting point apparatus. The high-resolution mass spectra (HRMS) were recorded using the electrospray ionization (ESI) (hybrid linear ion trap-orbitrap FT-MS and QqTOF/MS-Microtof-QII models).

General Procedures {#sec4.2}
------------------

γ-Nitro ester **2a** was prepared according to the procedure described by Li and co-workers.^[@ref33]^

### Ethyl 4-Nitro-3-phenylbutanoate **2a** {#sec4.2.1}

Colorless oil; 84% yield (5.40 g, 22.76 mmol); *R*~f~ = 0.43 (hexanes/AcOEt 7:3); IR ν~max~ = 3033, 2938, 2908, 1724, 1550, 1376, 1277, 1172, 1073, 1021, 764, 699 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.40--7.19 (m, 5H), 4.73 (dd, *J* = 12.6, 7.1 Hz, 1H), 4.64 (dd, *J* = 12.6, 7.9 Hz, 1H), 4.12--4.04 (m, 2H), 3.98 (quint, *J* = 7.4 Hz, 1H), 2.76 (dd, *J* = 7.4, 2.4 Hz, 2H), 1.17 (t, *J* = 7.2 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 170.5, 138.3, 129.0, 128.0, 127.3, 79.4, 60.9, 40.2, 37.8, 14.0 ppm.

General Procedure for the Synthesis of γ-Nitro Esters **2b**--**j**^[@ref33]−[@ref35]^ {#sec4.3}
--------------------------------------------------------------------------------------

In a 250 mL round-bottom flask, 685.0 mg of LiCl (16.2 mmol, 1.1 equiv) was previously dried under vacuum and 100 mL of anhydrous acetonitrile was added to the flask under argon atmosphere. Then, 2.9 mL of triethylphosphonoacetate (14.7 mmol, 1.0 equiv) and 2.1 g of 4-chlorobenzaldehyde (14.7 mmol, 1.0 equiv) were added, and the solution was stirred at 0 °C for 5 min. After this period, 2.2 mL of 1,8-diazabicyclo\[5.4.0\]undec-7-ene (14.7 mmol, 1.0 equiv) was added dropwise. The reaction was warmed to room temperature and stirred overnight. After this period, the reaction was diluted in diethyl ether and washed with a saturated solution of ammonium chloride and brine. The organic phase was dried over Na~2~SO~4~, filtered, and concentrated. To a 25 mL round-bottom flask with the crude reaction mixture of the first step was added 4.2 mL of anhydrous acetonitrile, and the system was cooled to −10 °C with a NaCl/ice bath. Then, 1.6 mL of nitromethane (29.4 mmol, 2.0 equiv) was added and the solution was stirred at 0 °C for 5 min. In sequence, 1.1 mL of 1,8-diazabicyclo\[5.4.0\]undec-7-ene (7.4 mmol, 0.5 equiv) was added dropwise. The reaction was warmed to room temperature and stirred for 16 h. After this period, the reaction was concentrated, and the crude reaction mixture was purified by flash column chromatography (Silica Gel, hexanes/AcOEt 9:1) to afford γ-nitro ester **2b** in 53% yield (2.1 g, 7.7 mmol) as a colorless oil.

### Ethyl 3-(4-Chlorophenyl)-4-nitrobutanoate **2b** {#sec4.3.1}

Colorless oil; 53% yield (2.1 g, 7.7 mmol); *R*~f~ = 0.44 (hexanes/AcOEt 1:1); IR ν~max~ = 2983, 2939, 2908, 2874, 1728, 1550, 1493, 1374, 1245, 1188, 1165, 1094, 1026, 828, 733, 718 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.31 (d, *J* = 8.3 Hz, 2H), 7.18 (d, *J* = 8.3 Hz, 2H), 4.72 (dd, *J* = 12.7, 6.7 Hz, 1H), 4.61 (dd, *J* = 12.6, 8.2 Hz, 1H), 4.15--4.02 (m, 2H), 4.02--3.90 (m, 1H), 2.80--2.66 (m, 2H), 1.18 (t, *J* = 7.1 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 170.3, 136.8, 133.9, 129.2, 128.7, 79.2, 61.0, 39.6, 37.6, 14.0 ppm.

### Ethyl 3-(4-Fluorophenyl)-4-nitrobutanoate **2c** {#sec4.3.2}

Colorless oil; 65% yield (2.15 g, 8.42 mmol); *R*~f~ = 0.44 (hexanes/AcOEt 7:3); IR ν~max~ = 2956, 2924, 2870, 2853, 1729, 1606, 1550, 1511, 1376, 1225, 1160, 1103, 1024, 835, 732 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.26--7.17 (m, 2H), 7.11--6.98 (m, 2H), 4.72 (dd, *J* = 12.6, 6.7 Hz, 1H), 4.61 (dd, *J* = 12.6, 8.2 Hz, 1H), 4.13--4.04 (m, 2H), 4.03--3.89 (m, 1H), 2.80--2.64 (m, 2H), 1.18 (t, *J* = 7.1 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 170.4, 162.3 (d, ^1^*J*~C--F~ = 246.6 Hz), 134.0 (d, ^4^*J*~C--F~ = 3.3 Hz), 129.0 (d, ^3^*J*~C--F~ = 8.1 Hz), 116.0 (d, ^2^*J*~C--F~ = 21.4 Hz), 79.4, 61.0, 39.5, 37.8, 14.0 ppm.

### Ethyl 3-(4-Methoxyphenyl)-4-nitrobutanoate **2d** {#sec4.3.3}

Colorless oil; 50% yield (2.10 g, 10.18 mmol); *R*~f~ = 0.57 (hexanes/AcOEt 1:1); IR ν~max~ = 2956, 2924, 2853, 1730, 1612, 1551, 1514, 1376, 1249, 1179, 1029, 831, 730 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.14 (d, *J* = 8.9 Hz, 2H), 6.86 (d, *J* = 8.8 Hz, 2H), 4.69 (dd, *J* = 12.4, 7.0 Hz, 1H), 4.59 (dd, *J* = 12.4, 8.1 Hz, 1H), 4.14--4.01 (m, 2H), 3.93 (quint, *J* = 7.5 Hz, 1H), 3.78 (s, 3H), 2.78--2.67 (m, 2H), 1.18 (t, *J* = 7.2 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 170.6, 159.2, 130.2, 128.4, 114.4, 79.7, 60.8, 55.2, 39.5, 37.9, 14.0 ppm.

### Ethyl 4-Nitro-3-(*p*-tolyl)butanoate **2e** {#sec4.3.4}

Colorless oil; 51% yield (1.80 g, 7.16 mmol); *R*~f~ = 0.19 (hexanes/AcOEt 7:3); IR ν~max~ = 3025, 2983, 2825, 2872, 1729, 1549, 1516, 1434, 1374, 1249, 1163, 1024, 817, 720 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.16--7.08 (m, 4H), 4.70 (dd, *J* = 12.5, 7.0 Hz, 1H), 4.61 (dd, *J* = 12.5, 7.9 Hz, 1H), 4.14--4.01 (m, 2H), 4.00--3.88 (m, 1H), 2.80--2.69 (m, 2H), 2.31 (s, 3H), 1.18 (t, *J* = 7.1 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 170.6, 137.7, 135.2, 129.7, 127.1, 79.6, 60.8, 39.9, 37.8, 21.0, 14.0 ppm.

### Ethyl 3-(Naphthalen-2-yl)-4-nitrobutanoate **2f** {#sec4.3.5}

Colorless oil; 67% yield (1.02 g, 3.55 mmol); *R*~f~ = 0.62 (hexanes/AcOEt 1:1); IR ν~max~ = 3056, 2958, 2925, 2870, 1727, 1548, 1433, 1374, 1349, 1256, 1245, 1177, 1096, 1023, 947, 894, 857, 819, 746, 684 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.87--7.67 (m, 4H), 7.52--7.42 (m, 2H), 7.33 (dd, *J* = 8.5, 1.9 Hz, 1H), 4.80 (dd, *J* = 12.6, 7.0 Hz, 1H), 4.72 (dd, *J* = 12.6, 7.9 Hz, 1H), 4.15 (quint, *J* = 7.4 Hz, 1H), 4.13--4.00 (m, 2H), 2.84 (d, *J* = 7.4 Hz, 2H), 1.14 (t, *J* = 7.1 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 170.5, 135.6, 133.3, 132.9, 129.0, 127.8, 127.6, 126.5 (2C), 126.3, 124.9, 79.4, 60.9, 40.3, 37.8, 14.0 ppm; HRMS (ESI-orbitrap) calcd for C~16~H~17~NNaO~4~ \[M + Na\]^+^ 310.10498 found 310.10548.

### Ethyl 3-(Nitromethyl)hexanoate **2g** {#sec4.3.6}

Colorless oil; 83% yield (7.50 g, 36.90 mmol); *R*~f~ = 0.56 (hexanes/AcOEt 1:1); IR ν~max~ = 2962, 2935, 2875, 1729, 1548, 1377, 1178, 1027, 736 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 4.51 (dd, *J* = 12.3, 6.5 Hz, 1H), 4.44 (dd, *J* = 12.3, 6.1 Hz, 1H), 4.16 (q, *J* = 7.1 Hz, 2H), 2.70--2.59 (m, 1H), 2.47--2.41 (m, 2H), 1.47--1.32 (m, 4H), 1.27 (t, *J* = 7.1 Hz, 3H), 1.00--0.88 (m, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 171.4, 78.5, 60.7, 35.8, 33.9, 33.5, 19.6, 14.1, 13.8 ppm.

### Ethyl 4-Methyl-3-(nitromethyl)pentanoate **2h** {#sec4.3.7}

Colorless oil; 50% yield (1.20 g, 5.90 mmol); *R*~f~ = 0.62 (hexanes/AcOEt 1:1); IR ν~max~ = 2965, 2918, 2878, 1730, 1550, 1375, 1178, 1108, 1030, 712 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 4.56--4.37 (m, 2H), 4.15 (q, *J* = 7.1 Hz, 2H), 2.60 (dtt, *J* = 8.0, 6.7, 5.3 Hz, 1H), 2.48 (dd, *J* = 16.3, 5.3 Hz, 1H), 2.33 (dd, *J* = 16.3, 8.1 Hz, 1H), 1.83 (septd, *J* = 7.0, 5.1 Hz, 1H), 1.27 (t, *J* = 7.1 Hz, 3H), 0.95 (dd, *J* = 6.5, 6.4 Hz, 6H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 171.8, 77.1, 60.8, 39.8, 33.3, 28.8, 19.3, 18.6, 14.1 ppm.

### Ethyl 3-(Nitromethyl)decanoate **2i** {#sec4.3.8}

Yellowish oil; 62% yield (2.10 g, 8.10 mmol); *R*~f~ = 0.71 (hexanes/AcOEt 1:1); IR ν~max~ = 2956, 2927, 2857, 1731, 1550, 1465, 1377, 1180, 1029, 891, 722 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 4.51 (dd, *J* = 12.2, 6.5 Hz, 1H), 4.44 (dd, *J* = 12.2, 6.1 Hz, 1H), 4.16 (q, *J* = 7.2 Hz, 2H), 2.62 (sept, *J* = 6.5 Hz, 1H), 2.45--2.41 (m, 2H), 1.46--1.22 (m, 15H), 0.88 (t, *J* = 7.0 Hz 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 171.5, 78.6, 60.7, 35.9, 34.2, 31.7, 31.4, 29.3, 29.0, 26.4, 22.6, 14.2, 14.0 ppm. HRMS (ESI-orbitrap) calcd for C~13~H~25~NNaO~4~ \[M + Na\]^+^ 282.16758 found 282.16425.

### Ethyl 3-Cyclohexyl-4-nitrobutanoate **2j** {#sec4.3.9}

Colorless oil; 70% yield (5.10 g, 20.96 mmol); *R*~f~ = 0.65 (hexanes/AcOEt 1:1); IR ν~max~ = 2981, 2927, 2854, 1730, 1549, 1447, 1375, 1209, 1177, 1093, 1029, 890, 729, 648 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 4.48 (d, *J* = 6.6 Hz, 2H), 4.15 (q, *J* = 7.2 Hz, 2H), 2.64--2.52 (m, 1H), 2.50 (dd, *J* = 16.3, 5.4 Hz, 1H), 2.35 (dd, *J* = 16.3, 7.9 Hz, 1H), 1.82--1.73 (m, 2H), 1.75--1.64 (m, 3H), 1.52--1.37 (m, 1H), 1.27 (t, *J* = 7.2 Hz, 3H), 1.26--1.16 (m, 2H), 1.18--1.05 (m, 1H), 1.06--0.91 (m, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 171.9, 77.1, 60.8, 39.4, 39.0, 33.6, 29.8, 29.3, 26.3, 26.2 (2C), 14.1 ppm. HRMS (ESI-orbitrap) calcd for C~12~H~21~NNaO~4~ \[M + Na\]^+^ 266.13628 found 266.13608.

General Procedure for the Synthesis of γ-*N*-(Trifluoroacetyl) Amino Acids **3a**--**j**^[@ref26]−[@ref28]^ {#sec4.4}
-----------------------------------------------------------------------------------------------------------

In a 100 mL round-bottom flask, 1.90 g of γ-nitro ester **2a** (8.0 mmol, 1.0 equiv) and 40.0 mL of anhydrous methanol were added under argon atmosphere. To the solution, 1.90 g of NiCl~2~.6H~2~O (8.0 mmol, 1.0 equiv) was added, and the suspension was stirred at −10 °C for 5 min. To the cooled suspension, 3.63 g of NaBH~4~ (96.0 mmol, 12.0 equiv) was added in portions (CAUTION: violent gas extrusion), and the reaction mixture was stirred for 16 h at room temperature. After this period, the reaction was quenched with a saturated solution of NH~4~Cl and extracted with CHCl~3~. The organic layer was dried over Na~2~SO~4~, filtered, and concentrated. To a 100 mL round-bottom flask with the crude reaction mixture of the first step was added 40 mL of a 6.0 N aqueous solution of HCl, and the reaction was allowed to reflux for 20 h. After this period, the reaction was cooled and extracted with diethyl ether. The aqueous phase was concentrated furnishing the amine hydrochloride salt as a pale yellow solid. To a 50 mL round-bottom flask were added amine hydrochloride salt secured in the second step and 13.0 mL of anhydrous methanol under argon atmosphere. The solution was cooled to 0 °C, and 5.57 mL of Et~3~N (40.0 mmol, 5.0 equiv) was added. The reaction was stirred at the same temperature for 10 min, then 3.38 mL of TFAA (24.0 mmol, 3.0 equiv) was added dropwise (CAUTION: gas extrusion), and the reaction was stirred at room temperature overnight. After this period, the reaction was concentrated and the crude reaction mixture was purified by flash column chromatography (Silica Gel, hexanes/AcOEt 1:1) to afford γ-*N*-(trifluoroacetyl) amino acid **3a** in 73% yield (1.61 g, 5.85 mmol) as a white solid.

### 3-Phenyl-4-(2,2,2-trifluoroacetamido)butanoic Acid **3a** {#sec4.4.1}

White solid; 73% yield (1.61 g, 5.85 mmol); mp = 97--99 °C; *R*~f~ = 0.21 (hexanes/AcOEt 1:1); IR ν~max~ = 3301, 3093, 3067, 3032, 1703, 1604, 1560, 1209, 1160, 762, 700 cm^--1^; ^1^H NMR (400 MHz, CD~3~OD) δ 7.35--7.17 (m, 5H), 3.54--3.49 (m, 2H), 3.48--3.36 (m, 1H), 2.72 (dd, *J* = 15.8, 6.2 Hz, 1H), 2.63 (dd, *J* = 15.8, 8.4 Hz, 1H) ppm; ^13^C NMR (101 MHz, CD~3~OD) δ 175.4, 159.0 (q, ^2^*J*~C--F~ = 36.9 Hz), 142.4, 129.6, 128.8, 128.1, 117.4 (q, ^1^*J*~C--F~ = 286.8 Hz), 45.8, 42.7, 39.1 ppm; HRMS (ESI-orbitrap) calcd for C~12~H~12~F~3~NNaO~3~ \[M + Na\]^+^ 298.06615 found 298.06714.

### 3-(4-Chlorophenyl)-4-(2,2,2-trifluoroacetamido)butanoic Acid **3b** {#sec4.4.2}

White solid; 40% yield (700.0 mg, 2.26 mmol); mp = 110--114 °C; *R*~f~ = 0.30 (hexanes/AcOEt 1:1); IR ν~max~ = 3301, 3106, 3033, 2942, 1704, 1559, 1494, 1415, 1209, 1161, 1093, 1014, 824, 720 cm^--1^; ^1^H NMR (500 MHz, CD~3~OD) δ 7.33--7.28 (m, 2H), 7.27--7.20 (m, 2H), 3.53--3.48 (m, 2H), 3.47--3.38 (m, 1H), 2.72 (dd, *J* = 16.0, 6.0 Hz, 1H), 2.62 (dd, *J* = 15.9, 8.7 Hz, 1H) ppm; ^13^C NMR (126 MHz, CD~3~OD) δ 175.1, 159.0 (q, ^2^*J*~C--F~ = 36.9 Hz), 141.1, 133.9, 130.5, 129.6, 117.4 (q, ^1^*J*~C--F~ = 286.7 Hz), 45.6, 42.1, 38.9 ppm; HRMS (ESI-orbitrap) calcd for C~12~H~11~ClF~3~NNaO~3~ \[M + Na\]^+^ 332.02718 found 332.02814.

### 3-(4-Fluorophenyl)-4-(2,2,2-trifluoroacetamido)butanoic Acid **3c** {#sec4.4.3}

White solid; 51% yield (1.25 g, 4.26 mmol); mp = 89--93 °C; *R*~f~ = 0.34 (hexanes/AcOEt 1:1 developed 2×); IR ν~max~ = 3308, 3110, 2955, 2925, 2851, 1707, 1606, 1558, 1512, 1212, 1161, 833, 723 cm^--1^; ^1^H NMR (500 MHz, CD~3~OD) δ 7.31--7.23 (m, 2H), 7.07--6.98 (m, 2H), 3.52--3.48 (m, 2H), 3.43 (tt, *J* = 8.6, 6.2 Hz, 1H), 2.71 (dd, *J* = 15.9, 6.1 Hz, 1H), 2.61 (dd, *J* = 15.9, 8.6 Hz, 1H) ppm; ^13^C NMR (126 MHz, CD~3~OD) δ 175.2, 163.3 (d, ^1^*J*~C--F~ = 243.6 Hz), 159.0 (q, ^2^*J*~C--F~ = 36.9 Hz), 138.3 (d, ^4^*J*~C--F~ = 3.3 Hz), 130.6 (d, ^3^*J*~C--F~ = 8.0 Hz), 117.4 (q, ^1^*J*~C--F~ = 287.7 Hz), 116.2 (d, ^2^*J*~C--F~ = 21.5 Hz), 45.7, 42.0, 39.1 ppm; HRMS (ESI-orbitrap) calcd for C~12~H~11~F~4~NNaO~3~ \[M + Na\]^+^ 316.05673 found 316.05756.

### 3-(4-Methoxyphenyl)-4-(2,2,2-trifluoroacetamido)butanoic Acid **3d** {#sec4.4.4}

Pale yellow solid; 40% yield (350.0 mg, 1.15 mmol); mp = 66--69 °C; *R*~f~ = 0.21 (hexanes/AcOEt 1:1); IR ν~max~ = 3301, 3106, 2955, 2938, 1705, 1612, 1560, 1514, 1211, 1178, 1161, 830, 724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.12 (d, *J* = 8.8 Hz, 2H), 6.88 (d, *J* = 8.8 Hz, 2H), 6.45 (bs, 1H), 3.80 (s, 3H), 3.78--3.66 (m, 1H), 3.51--3.39 (m, 1H), 3.34 (quint, *J* = 7.3 Hz, 1H), 2.71 (dd, *J* = 7.2, 1.8 Hz, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 176.9, 159.1, 157.3 (q, ^2^*J*~C--F~ = 37.1 Hz), 131.6, 128.3, 115.7 (q, ^1^*J*~C--F~ = 287.7 Hz), 114.5, 55.3, 44.8, 40.1, 38.2 ppm. HRMS (ESI-orbitrap) calcd for C~13~H~14~F~3~NNaO~4~ \[M + Na\]^+^ 328.07671 found 328.07527.

### 3-(*p*-Tolyl)-4-(2,2,2-trifluoroacetamido)butanoic Acid **3e** {#sec4.4.5}

White solid; 55% yield (500.0 mg, 1.73 mmol); mp = 130--135 °C; *R*~f~ = 0.42 (hexanes/AcOEt 1:1 developed 2×); IR ν~max~ = 3321, 3028, 3011, 2948, 2925, 2872, 1697, 1559, 1455, 1302, 1174, 1153, 924, 809, 703 cm^--1^; ^1^H NMR (500 MHz, CD~3~OD) δ 7.16--7.07 (m, 4H), 3.53--3.43 (m, 2H), 3.42--3.33 (m, 1H), 2.69 (dd, *J* = 15.7, 6.2 Hz, 1H), 2.59 (dd, *J* = 15.8, 8.5 Hz, 1H), 2.29 (s, 3H) ppm; ^13^C NMR (126 MHz, CD~3~OD) δ 175.5, 159.0 (q, ^2^*J*~C--F~ = 36.9 Hz), 139.2, 137.8, 130.2, 128.6, 117.4 (q, ^1^*J*~C--F~ = 286.7 Hz), 45.9, 42.2, 39.2, 21.1 ppm; HRMS (ESI-orbitrap) calcd for C~13~H~14~F~3~NNaO~3~ \[M + Na\]^+^ 312.08180 found 312.08992.

### 3-(Naphthalen-2-yl)-4-(2,2,2-trifluoroacetamido)butanoic Acid **3f** {#sec4.4.6}

White semisolid; 61% yield (740.0 mg, 2.28 mmol); *R*~f~ = 0.37 (hexanes/AcOEt 1:1); IR ν~max~ = 3296, 3056, 2980, 2971, 1698, 1558, 1439, 1411, 1151, 858, 817, 747 cm^--1^; ^1^H NMR (400 MHz, CD~3~OD) δ 7.86--7.76 (m, 3H), 7.72 (d, *J* = 1.7 Hz, 1H), 7.49--7.35 (m, 3H), 3.76--3.49 (m, 3H), 2.87--2.66 (m, 2H) ppm; ^13^C NMR (126 MHz, CD~3~OD) δ 175.4, 159.1 (q, ^2^*J*~C--F~ = 36.8 Hz), 139.7, 134.9, 134.2, 129.3, 128.7, 128.6, 127.6, 127.1, 126.8, 126.7, 117.4 (q, ^1^*J*~C--F~ = 286.7 Hz), 45.8, 42.8, 39.1 ppm; HRMS (ESI-orbitrap) calcd for C~16~H~14~F~3~NNaO~3~ \[M + Na\]^+^ 348.08180 found 348.08282.

### 3-((2,2,2-Trifluoroacetamido)methyl)hexanoic Acid **3g** {#sec4.4.7}

White solid; 83% yield (1.10 g, 4.56 mmol); mp = 79--83 °C; *R*~f~ = 0.24 (hexanes/AcOEt 1:1); IR ν~max~ = 3307, 3102, 2962, 2921, 2877, 1690, 1558, 1443, 1164, 940, 724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.05 (bs, 1H), 3.47 (dt, *J* = 13.8, 5.3 Hz, 1H), 3.37--3.27 (m, 1H), 2.48 (dd, *J* = 16.2, 4.8 Hz, 1H), 2.35 (dd, *J* = 16.2, 7.8 Hz, 1H), 2.24--2.09 (m, 1H), 1.51--1.25 (m, 4H), 0.93 (t, *J* = 6.8 Hz, 3H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 178.9, 157.6 (q, ^2^*J*~C--F~ = 37.0 Hz), 115.9 (q, ^1^*J*~C--F~ = 287.8 Hz), 43.7, 36.9, 34.4 (2C), 19.8, 13.9 ppm; HRMS (ESI-orbitrap) calcd for C~9~H~14~F~3~NNaO~3~ \[M + Na\]^+^ 264.08180 found 264.08181.

### 4-Methyl-3-((2,2,2-trifluoroacetamido)methyl)pentanoic Acid **3h** {#sec4.4.8}

White solid; 65% yield (585.0 mg, 2.43 mmol); mp = 85--89 °C; *R*~f~ = 0.45 (hexanes/AcOEt 1:1); IR ν~max~ = 3301, 3109, 2963, 2929, 2880, 1701, 1560, 1393, 1157, 726 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.16 (bs, 1H), 3.48 (ddd, *J* = 13.8, 5.1, 5.0 Hz, 1H), 3.33 (ddd, *J* = 13.8, 8.8, 5.9 Hz, 1H), 2.52 (dd, *J* = 16.5, 3.7 Hz, 1H), 2.31 (dd, *J* = 16.5, 8.8 Hz, 1H), 2.08--1.97 (m, 1H), 1.85--1.72 (m, 1H), 0.95 (dd, *J* = 7.5, 7.1 Hz, 6H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 179.4, 157.5 (q, ^2^*J*~C--F~ = 36.8 Hz), 115.9 (q, ^1^*J*~C--F~ = 287.8 Hz), 42.4, 40.3, 34.7, 29.9, 19.5, 18.8 ppm; HRMS (ESI-orbitrap) calcd for C~9~H~14~F~3~NNaO~3~ \[M + Na\]^+^ 264.08180 found 264.08246.

### 3-((2,2,2-Trifluoroacetamido)methyl)decanoic Acid **3i** {#sec4.4.9}

White solid; 65% yield (1.30 g, 4.37 mmol); mp = 65--69 °C; *R*~f~ = 0.39 (hexanes/AcOEt 1:1); IR ν~max~ = 3303, 3108, 2956, 2928, 2858, 1705, 1561, 1456, 1445, 1210, 1181, 1164, 936, 724 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 9.44 (s, 1H), 7.14 (bs, 1H), 3.46 (ddd, *J* = 13.8, 5.9, 5.4 Hz, 1H), 3.31 (ddd, *J* = 13.8, 7.9, 6.4 Hz, 1H), 2.47 (dd, *J* = 16.2, 4.8 Hz, 1H), 2.35 (dd, *J* = 16.2, 7.8 Hz, 1H), 2.22--2.08 (m, 1H), 1.42--1.21 (m, 12H), 0.92--0.85 (t, *J* = 7.0 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 178.9, 157.6 (q, ^2^*J*~C--F~ = 37.0 Hz), 115.8 (q, ^1^*J*~C--F~ = 287.7 Hz), 43.7, 37.0, 34.6, 32.2, 31.7, 29.5, 29.1, 26.6, 22.6, 14.0 ppm; HRMS (ESI-orbitrap) calcd for C~13~H~22~F~3~NNaO~3~ \[M + Na\]^+^ 320.14440 found 320.14448.

### 3-Cyclohexyl-4-(2,2,2-trifluoroacetamido)butanoic Acid **3j** {#sec4.4.10}

White solid; 40% yield (2.17 g, 7.71 mmol); mp = 96--99 °C; *R*~f~ = 0.37 (hexanes/AcOEt 1:1); IR ν~max~ = 3303, 3106, 2926, 2855, 1701, 1560, 1449, 1203, 1154, 893, 725 cm^--1^; ^1^H NMR (500 MHz, CD~3~OD) δ 3.40 (dd, *J* = 13.5, 6.0 Hz, 1H), 3.22 (dd, *J* = 13.5, 8.2 Hz, 1H), 2.36 (dd, *J* = 16.0, 5.9 Hz, 1H), 2.20 (dd, *J* = 16.0, 7.3 Hz, 1H), 2.12--2.01 (m, 1H), 1.83--1.73 (m, 2H), 1.73--1.61 (m, 3H), 1.47--1.35 (m, 1H), 1.33--1.02 (m, 5H) ppm; ^13^C NMR (126 MHz, CD~3~OD) δ 177.0, 159.2 (q, ^2^*J*~C--F~ = 36.7 Hz), 117.6 (q, ^1^*J*~C--F~ = 286.8 Hz), 42.5, 41.4, 40.8, 35.2, 31.0, 30.3, 27.8 (2C), 27.6 ppm. HRMS (ESI-orbitrap) calcd for C~12~H~18~F~3~NNaO~3~ \[M + Na\]^+^ 304.11310 found 304.11290.

Synthesis of γ-*N*-(Trifluoroacetyl) Amino Diazoketones **4a**--**k** {#sec4.5}
---------------------------------------------------------------------

The γ-*N*-(trifluoroacetyl) amino diazoketones **4a**--**j** were prepared according to the procedure described by Pinho and Burtoloso^[@ref29]^ for the one-step carboxylic acid activation and diazomethane acylation. The γ-*N*-(trifluoroacetyl) amino diazoketone **4k** was prepared following the same protocol, although an ethereal solution of diazoethane was employed.

### *N*-(5-Diazo-4-oxo-2-phenylpentyl)-2,2,2-trifluoroacetamide **4a** {#sec4.5.1}

Yellow solid; 94% yield (511.0 mg, 1.71 mmol); mp = 88--91 °C; *R*~f~ = 0.47 (hexanes/AcOEt 1:1); IR ν~max~ = 3092, 3032, 2918, 2850, 2105, 1709, 1625, 1556, 1372, 1207, 1151, 724, 700 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.39--7.29 (m, 2H), 7.33--7.23 (m, 1H), 7.23--7.11 (m, 3H), 5.24 (s, 1H), 3.73--3.61 (m, 1H), 3.60--3.42 (m, 2H), 2.78--2.68 (m, 2H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 193.2, 157.3 (q, ^2^*J*~C--F~ = 37.0 Hz), 140.6, 129.1, 127.6, 127.2, 115.8 (q, ^1^*J*~C--F~ = 287.7 Hz), 55.9, 45.1, 44.7, 40.8 ppm; HRMS (ESI-orbitrap) calcd for C~13~H~12~F~3~N~3~NaO~2~ \[M + Na\]^+^ 322.07738 found 322.07876.

### *N*-(2-(4-Chlorophenyl)-5-diazo-4-oxopentyl)-2,2,2-trifluoroacetamide **4b** {#sec4.5.2}

Yellow solid; 74% yield (200.0 mg, 0.60 mmol); mp = 107--111 °C; *R*~f~ = 0.47 (hexanes/AcOEt 1:1); IR ν~max~ = 3300, 3099, 2932, 2105, 1709, 1626, 1556, 1493, 1373, 1177, 1153, 1014, 825, 701 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.37--7.26 (m, 2H), 7.25--7.18 (m, 1H), 7.17--7.09 (m, 2H), 5.25 (s, 1H), 3.71--3.58 (m, 1H), 3.58--3.44 (m, 2H), 2.83--2.55 (m, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 192.8, 157.4 (q, ^2^*J*~C--F~ = 36.8 Hz), 139.1, 133.4, 129.2, 128.6, 116.9 (q, ^1^*J*~C--F~ = 287.8 Hz), 56.0, 44.9, 44.5, 40.3 ppm; HRMS (ESI-orbitrap) calcd for C~13~H~11~ClF~3~N~3~NaO~2~ \[M + Na\]^+^ 356.03841 found 356.03658.

### *N*-(5-Diazo-2-(4-fluorophenyl)-4-oxopentyl)-2,2,2-trifluoroacetamide **4c** {#sec4.5.3}

Yellow solid; 51% yield (180.0 mg, 0.57 mmol); mp = 99--104 °C; *R*~f~ = 0.39 (hexanes/AcOEt 1:1); IR ν~max~ = 3098, 2929, 2855, 2105, 1709, 1625, 1557, 1510, 1373, 1208, 1178, 1151, 834, 722 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.22--7.12 (m, 3H), 7.08--6.97 (m, 2H), 5.24 (s, 1H), 3.71--3.58 (m, 1H), 3.58--3.42 (m, 2H), 2.84--2.55 (m, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 193.0, 162.0 (d, ^1^*J*~C--F~ = 246.4 Hz), 157.4 (q, ^2^*J*~C--F~ = 37.1 Hz), 136.4 (d, ^4^*J*~C--F~ = 3.2 Hz), 128.8 (d, ^3^*J*~C--F~ = 8.1 Hz), 115.9 (d, ^2^*J*~C--F~ = 21.4 Hz), 115.8 (q, ^1^*J*~C--F~ = 287.2 Hz) 55.9, 45.1, 44.7, 40.2 ppm; HRMS (ESI-orbitrap) calcd for C~13~H~11~F~4~N~3~NaO~2~ \[M + Na\]^+^ 340.06796 found 340.06860.

### *N*-(5-Diazo-2-(4-methoxyphenyl)-4-oxopentyl)-2,2,2-trifluoroacetamide **4d** {#sec4.5.4}

Pale yellow solid; 80% yield (215.0 mg, 0.65 mmol); mp = 100--104 °C; *R*~f~ = 0.37 (hexanes/AcOEt 1:1); IR ν~max~ = 3098, 2938, 2839, 2105, 1711, 1613, 1557, 1514, 1373, 1178, 1154, 1033, 830, 723 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.11 (d, *J* = 8.7 Hz, 2H), 7.05 (bs, 1H), 6.87 (d, *J* = 8.7 Hz, 2H), 5.22 (s, 1H), 3.80 (s, 3H), 3.69--3.60 (m, 1H), 3.54--3.37 (m, 2H), 2.76--2.58 (m, 2H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 193.3, 158.9, 157.3 (q, ^2^*J*~C--F~ = 36.9 Hz), 132.5, 128.3, 115.8 (q, ^1^*J*~C--F~ = 287.0 Hz), 114.4, 55.8, 55.3, 45.2, 45.0, 40.1 ppm; HRMS (ESI-orbitrap) calcd for C~14~H~14~F~3~N~3~NaO~3~ \[M + Na\]^+^ 352.08795 found 352.08655.

### *N*-(5-Diazo-4-oxo-2-(*p*-tolyl)pentyl)-2,2,2-trifluoroacetamide **4e** {#sec4.5.5}

Yellow solid; 81% yield (220.0 mg, 0.70 mmol); mp = 94--96 °C; *R*~f~ = 0.48 (hexanes/AcOEt 1:1); IR ν~max~ = 3096, 2980, 2971, 2927, 2104, 1709, 1625, 1557, 1371, 1207, 1152, 815, 721 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.15 (d, *J* = 8.0 Hz, 2H), 7.12--7.03 (m, 3H), 5.23 (s, 1H), 3.65 (ddd, *J* = 13.8, 7.9, 6.1 Hz, 1H), 3.56--3.46 (m, 1H), 3.43 (quint, *J* = 7.0 Hz, 1H), 2.79--2.61 (m, 2H), 2.33 (s, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 193.3, 157.3 (q, ^2^*J*~C--F~ = 36.9 Hz), 137.5, 137.3, 129.7, 127.1, 115.8 (q, ^1^*J*~C--F~ = 287.7 Hz), 55.8, 45.2, 44.8, 40.4, 21.0 ppm; HRMS (ESI-orbitrap) calcd for C~14~H~14~F~3~N~3~NaO~2~ \[M + Na\]^+^ 336.09303 found 336.09289.

### *N*-(5-Diazo-2-(naphthalen-2-yl)-4-oxopentyl)-2,2,2-trifluoroacetamide **4f** {#sec4.5.6}

Yellow solid; 30% yield (80.0 mg, 0.23 mmol); mp = 114--117 °C; *R*~f~ = 0.41 (hexanes/AcOEt 1:1); IR ν~max~ = 3090, 2955, 2924, 2853, 2104, 1710, 1629, 1556, 1367, 1333, 1207, 1151, 858, 747, 725 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.89--7.76 (m, 3H), 7.64 (s, 1H), 7.56--7.44 (m, 2H), 7.31 (dd, *J* = 8.5, 1.7 Hz, 1H), 7.08 (s, 1H), 5.23 (s, 1H), 3.84--3.72 (m, 1H), 3.71--3.56 (m, 2H), 2.91--2.71 (m, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 193.1, 157.4 (q, ^2^*J*~C--F~ = 36.7 Hz), 138.0, 133.4, 132.7, 129.0, 127.7 (2C), 126.6, 126.2 (2C), 125.0, 115.8 (q, ^1^*J*~C--F~ = 287.7 Hz), 55.9, 45.0, 44.8, 40.9 ppm. HRMS (ESI-orbitrap) calcd for C~17~H~14~F~3~N~3~NaO~2~ \[M + Na\]^+^ 372.09303 found 372.09437.

### *N*-(5-Diazo-4-oxo-2-propylpentyl)-2,2,2-trifluoroacetamide **4g** {#sec4.5.7}

Yellow solid; 50% yield (110.0 mg, 0.42 mmol); mp = 55--58 °C; *R*~f~ = 0.45 (hexanes/AcOEt 1:1); IR ν~max~ = 3080, 2959, 2926, 2875, 2103, 1706, 1621, 1466, 1373, 1149, 722 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.78 (bs, 1H), 5.33 (s, 1H), 3.42 (dt, *J* = 13.8, 4.7 Hz, 1H), 3.25 (ddd, *J* = 13.8, 8.4, 6.0 Hz, 1H), 2.51--2.49 (m, 1H), 2.38--2.25 (m, 1H), 2.25--2.11 (m, 1H), 1.44--1.24 (m, 4H), 0.92 (t, *J* = 6.8 Hz, 3H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 195.1, 157.5 (q, ^2^*J*~C--F~ = 37.0 Hz), 116.0 (q, ^1^*J*~C--F~ = 287.5 Hz), 56.0, 44.2, 43.9, 34.9, 34.5, 20.0, 14.0 ppm; HRMS (ESI-orbitrap) calcd for C~10~H~14~F~3~N~3~NaO~2~ \[M + Na\]^+^ 288.09303 found 288.09299.

### *N*-(5-Diazo-2-isopropyl-4-oxopentyl)-2,2,2-trifluoroacetamide **4h** {#sec4.5.8}

Yellow solid; 50% yield (139.0 mg, 0.52 mmol); mp = 65--68 °C; *R*~f~ = 0.53 (hexanes/AcOEt 1:1); IR ν~max~ = 3089, 2966, 2930, 2880, 2106, 1712, 1625, 1557, 1372, 1359, 1149, 721 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.91 (bs, 1H), 5.34 (s, 1H), 3.48--3.36 (m, 1H), 3.27 (ddd, *J* = 13.8, 9.5, 5.4 Hz, 1H), 2.47 (d, *J* = 16.3 Hz, 1H), 2.29 (dd, *J* = 16.3, 8.9 Hz, 1H), 2.12--1.99 (m, 1H), 1.84--1.71 (m, 1H), 0.93 (dd, *J* = 6.9, 4.5 Hz, 6H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 195.6, 157.4 (q, ^2^*J*~C--F~ = 36.7 Hz), 116.0 (q, ^1^*J*~C--F~ = 286.7 Hz), 55.9, 42.9, 41.6, 40.0, 30.4, 19.6, 19.1 ppm; HRMS (ESI-orbitrap) calcd for C~10~H~14~F~3~N~3~NaO~2~ \[M + Na\]^+^ 288.09303 found 288.09296.

### *N*-(2-(3-Diazo-2-oxopropyl)nonyl)-2,2,2-trifluoroacetamide **4i** {#sec4.5.9}

Yellow solid; 72% yield (194.0 mg, 0.60 mmol); mp = 39--43 °C; *R*~f~ = 0.56 (hexanes/AcOEt 1:1); IR ν~max~ = 3094, 2955, 2925, 2856, 2105, 1709, 1626, 1556, 1460, 1376, 1351, 1207, 1178, 1152, 722 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.76 (bs, 1H), 5.33 (s, 1H), 3.42 (ddd, *J* = 13.8, 5.4, 4.8 Hz, 1H), 3.24 (ddd, *J* = 13.8, 8.3, 5.7 Hz, 1H), 2.51--2.39 (m, 1H), 2.31 (dd, *J* = 15.8, 8.3 Hz, 1H), 2.24--2.08 (m, 1H), 1.43--1.16 (m, 12H), 0.88 (t, *J* = 6.9 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 195.1, 157.5 (q, ^2^*J*~C--F~ = 36.7 Hz), 116.0 (q, ^1^*J*~C--F~ = 287.7 Hz), 56.0, 44.2, 43.9, 34.7, 32.8, 31.7, 29.5, 29.1, 26.8, 22.6, 14.0 ppm; HRMS (ESI-orbitrap) calcd for C~14~H~22~F~3~N~3~NaO~2~ \[M + H\]^+^ 344.15563 found 344.15700.

### *N*-(2-Cyclohexyl-5-diazo-4-oxopentyl)-2,2,2-trifluoroacetamide **4j** {#sec4.5.10}

Yellowish solid; 30% yield (195.0 mg, 0.64 mmol); mp = 76--79 °C; *R*~f~ = 0.43 (hexanes/AcOEt 1:1); IR ν~max~ = 3096, 2926, 2854, 2105, 1714, 1638, 1556, 1359, 1257, 1177, 1151, 1015, 724 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.95 (bs, 1H), 5.34 (s, 1H), 3.42 (dt, *J* = 13.7, 4.5 Hz, 1H), 3.29 (ddd, *J* = 14.1, 9.5, 5.5 Hz, 1H), 2.58--2.44 (m, 1H), 2.32 (dd, *J* = 16.3, 8.8 Hz, 1H), 2.12--1.96 (m, 1H), 1.85--1.72 (m, 2H), 1.72--1.59 (m, 3H), 1.44--1.32 (m, 1H), 1.29--1.16 (m, 2H), 1.13 (tt, *J* = 12.8, 3.3 Hz, 1H), 1.09--0.97 (m, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 195.8, 157.4 (q, ^2^*J*~C--F~ = 36.7 Hz), 116.0 (q, ^1^*J*~C--F~ = 287.6 Hz), 55.9, 42.9, 42.1, 40.8, 39.6, 29.9, 29.8, 26.4 (2C), 26.3 ppm. HRMS (ESI-orbitrap) calcd for C~13~H~18~F~3~N~3~NaO~2~ \[M + Na\]^+^ 328.12433 found 328.12290.

### *N*-(5-Diazo-4-oxo-2-phenylhexyl)-2,2,2-trifluoroacetamide **4k** {#sec4.5.11}

Viscous yellow oil; 21% yield (50.0 mg, 0.15 mmol); *R*~f~ = 0.47 (hexanes/AcOEt 1:1); IR ν~max~ = 3089, 3066, 2953, 2870, 2854, 2079, 1709, 1614, 1555, 1376, 1207, 1153, 1044, 760, 701 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.40--7.32 (m, 2H), 7.31--7.25 (m, 1H), 7.24--7.16 (m, 2H), 7.04 (bs, 1H), 3.77--3.62 (m, 1H), 3.61--3.44 (m, 2H), 2.96--2.72 (m, 2H), 1.91 (s, 3H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 192.6, 157.3 (q, ^2^*J*~C--F~ = 36.9 Hz), 140.7, 129.1, 127.6, 127.2, 115.8 (q, ^1^*J*~C--F~ = 287.9 Hz), 63.8, 45.0, 41.9, 40.6, 8.1 ppm. HRMS (ESI-orbitrap) calcd for C~14~H~14~F~3~N~3~NaO~2~ \[M + Na\]^+^ 336.09303 found 336.09642.

General Procedure for the Synthesis of Bicyclic \[1,2,3\]-Triazole Cores **5a**--**k** {#sec4.6}
--------------------------------------------------------------------------------------

To a 5 mL round-bottom flask equipped with a magnetic stir bar were added 25.0 mg of *N*-(trifluoroacetyl) amino diazoketone **4a** (0.084 mmol, 1.0 equiv) and 1.7 mL of methanol. Then, 0.35 mL of K~2~CO~3~ 5% aqueous solution (0.13 mmol, 1.5 equiv) was added and the reaction mixture was stirred over reflux for 75 min. After this period, the reaction solution was cooled to room temperature and concentrated. The reaction mixture was purified by flash chromatography with a short pad of silica (CHCl~3~ as eluent) to furnish the fused bicyclic \[1,2,3\]-triazole **5a** in 91% yield (14.0 mg, 0.076 mmol) as a pale yellow solid.

### 5-Phenyl-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5a** {#sec4.6.1}

Pale yellow solid; 91% yield (14.0 mg, 0.08 mmol); mp = 64--68 °C; *R*~f~ = 0.19 (hexanes/AcOEt 1:1); IR ν~max~ = 3134, 3085, 3061, 3029, 2959, 2919, 2850, 1602, 1548, 1496, 1455, 1309, 1211, 1092, 995, 821, 762, 700 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.48 (s, 1H), 7.40--7.35 (m, 2H), 7.34--7.30 (m, 1H), 7.26--7.23 (m, 2H), 4.83--4.74 (m, 1H), 4.43--4.31 (m, 2H), 3.45--3.32 (m, 1H), 3.08--2.96 (m, 1H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 140.8, 140.5, 129.2, 127.8, 127.1, 126.8, 53.2, 48.5, 29.6 ppm; HRMS (ESI-orbitrap) calcd for C~11~H~12~N~3~ \[M + H\]^+^ 186.10257 found 186.10208.

### 5-(4-Chlorophenyl)-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5b** {#sec4.6.2}

Pale yellow solid; 85% yield (13.9 mg, 0.06 mmol); mp = 64--68 °C; *R*~f~ = 0.23 (hexanes/AcOEt 1:1); IR ν~max~ = 2956, 2923, 2851, 1646, 1599, 1548, 1494, 1454, 1377, 1311, 1212, 1090, 1014, 995, 820, 760 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.47 (s, 1H), 7.41--7.29 (m, 2H), 7.27--7.15 (m, 2H), 4.84--4.71 (m, 1H), 4.42--4.24 (m, 2H), 3.40 (dd, *J* = 16.0, 8.2 Hz, 1H), 3.07--2.93 (m, 1H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 140.6, 139.0, 133.6, 129.3, 128.1, 127.1, 53.0, 47.8, 29.6 ppm; HRMS (ESI-orbitrap) calcd for C~11~H~10~ClN~3~Na \[M + H\]^+^ 220.06360 found 220.06245.

### 5-(4-Fluorophenyl)-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5c** {#sec4.6.3}

Pale yellow solid; 94% yield (15 mg, 0.07 mmol); mp = 55--59 °C; *R*~f~ = 0.15 (hexanes/AcOEt 1:1); IR ν~max~ = 2956, 2923, 2851, 1688, 1658, 1604, 1511, 1453, 1377, 1312, 1220, 1161, 1095, 996, 834, 809, 721 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.47 (s, 1H), 7.26--7.18 (m, 2H), 7.13--7.01 (m, 2H), 4.86--4.67 (m, 1H), 4.45--4.24 (m, 2H), 3.39 (dd, *J* = 16.0, 8.2 Hz, 1H), 3.07--2.93 (m, 1H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 162.1 (d, ^1^*J*~C--F~ = 246.6 Hz), 140.6, 136.3 (d, ^4^*J*~C--F~ = 3.3 Hz), 128.4 (d, ^3^*J*~C--F~ = 8.0 Hz), 127.1, 116.0 (d, ^2^*J*~C--F~ = 21.4 Hz), 53.2, 47.7, 29.7 ppm; HRMS (ESI-orbitrap) calcd for C~11~H~11~FN~3~ \[M + H\]^+^ 204.09315 found 204.09297.

### 5-(4-Methoxyphenyl)-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5d** {#sec4.6.4}

Pale yellow solid; 92% yield (15.0 mg, 0.07 mmol); mp = 44--48 °C; *R*~f~ = 0.19 (hexanes/AcOEt 1:1); IR ν~max~ = 2958, 2919, 2850, 1613, 1514, 1462, 1455, 1306, 1290, 1247, 1212, 1029, 827, 795, 726, 690, 652 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.46 (s, 1H), 7.17 (d, *J* = 8.7 Hz, 2H), 6.90 (d, *J* = 8.7 Hz, 2H), 4.83--4.65 (m, 1H), 4.38--4.24 (m, 2H), 3.81 (s, 3H), 3.36 (dd, *J* = 15.9, 8.5 Hz, 1H), 2.98 (dd, 15.9, 7.8 1H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 159.0, 140.8, 132.4, 127.9, 127.0, 114.4, 55.3, 53.4, 47.8, 29.8 ppm; HRMS (ESI-orbitrap) calcd for C~12~H~14~N~3~O \[M + H\]^+^ 216.11314 found 216.11290.

### 5-(*p*-Tolyl)-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5e** {#sec4.6.5}

Pale yellow solid; 94% yield (15.0 mg, 0.08 mmol); mp = 91--94 °C; *R*~f~ = 0.25 (hexanes/AcOEt 1:1); IR ν~max~ = 3048, 3022, 2921, 2861, 1651, 1548, 1518, 1451, 1307, 1229, 1212, 1092, 996, 816, 719, 692, 654 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.46 (s, 1H), 7.18 (d, *J* = 8.0 Hz, 2H), 7.14 (d, *J* = 8.1 Hz, 2H), 4.80--4.70 (m, 1H), 4.37--4.26 (m, 2H), 3.42--3.29 (m, 1H), 3.05--2.94 (m, 1H), 2.35 (s, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 140.9, 137.5, 137.4, 129.7, 127.0, 126.7, 53.3, 48.1, 29.7, 21.0 ppm; HRMS (ESI-orbitrap) calcd for C~12~H~14~N~3~ \[M + H\]^+^ 200.11822 found 200.11777.

### 5-(Naphthalen-2-yl)-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5f** {#sec4.6.6}

Pale yellow solid; 80% yield (13.0 mg, 0.06 mmol); mp = 121--125 °C; *R*~f~ = 0.24 (hexanes/AcOEt 1:1); IR ν~max~ = 3020, 2956, 2924, 2852, 1689, 1667, 1548, 1508, 1377, 1307, 1213, 1126, 996, 860, 820, 750 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.90--7.77 (m, 3H), 7.70 (s, 1H), 7.56--7.46 (m, 3H), 7.34 (dd, *J* = 8.6, 1.9 Hz, 1H), 4.84 (dd, *J* = 11.4, 8.4 Hz, 1H), 4.53 (quint, *J* = 8.1 Hz, 1H), 4.46 (dd, *J* = 11.4, 7.8 Hz, 1H), 3.46 (dd, *J* = 15.9, 8.4 Hz, 1H), 3.13 (dd, *J* = 15.9, 7.5 Hz, 1H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 140.8, 137.7, 133.3, 132.7, 129.2, 127.7 (2C), 127.1, 126.7, 126.3, 125.6, 124.5, 53.1, 48.6, 29.6 ppm; HRMS (ESI-orbitrap) calcd for C~15~H~14~N~3~ \[M + H\]^+^ 236.11822 found 236.11805.

### 5-Propyl-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5g** {#sec4.6.7}

Pale yellow viscous oil; 95% yield (13.5 mg, 0.09 mmol); *R*~f~ = 0.33 (hexanes/AcOEt 1:1); IR ν~max~ = 2958, 2927, 2871, 1725, 1548, 1454, 1380, 1309, 1212, 1093, 994, 813, 743, 692, 651 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.39 (s, 1H), 4.49 (dd, *J* = 11.5, 8.2 Hz, 1H), 3.93 (dd, *J* = 11.5, 7.6 Hz, 1H), 3.19 (hept, *J* = 7.6 Hz, 1H), 3.07 (dd, *J* = 15.6, 8.2 Hz, 1H), 2.56 (dd, *J* = 15.6, 7.2 Hz, 1H), 1.67--1.59 (m, 2H), 1.47--1.34 (m, 2H), 0.98 (t, *J* = 7.3 Hz, 3H) ppm; ^13^C NMR (101 MHz, CDCl~3~) δ 141.1, 127.0, 51.8, 43.4, 36.5, 27.3, 20.7, 13.9 ppm; HRMS (ESI-orbitrap) calcd for C~8~H~13~N~3~Na \[M + Na\]^+^ 174.10017 found 174.10241.

### 5-Isopropyl-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5h** {#sec4.6.8}

Pale yellow viscous oil; 88% yield (15.0 mg, 0.01 mmol); *R*~f~ = 0.21 (hexanes/AcOEt 1:1); IR ν~max~ = 2959, 2918, 2872, 2850, 1694, 1666, 1558, 1466, 1389, 1371, 1285, 1216, 1143, 1093, 995, 814, 758 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.39 (s, 1H), 4.47 (dd, *J* = 11.5, 8.4 Hz, 1H), 3.98 (dd, *J* = 11.5, 8.6 Hz, 1H), 3.03 (dd, *J* = 15.5, 8.4 Hz, 1H), 2.94 (sext, *J* = 8.4 Hz, 1H), 2.61 (dd, *J* = 15.4, 8.0 Hz, 1H), 1.95--1.78 (m, 1H), 1.01 (d, *J* = 3.4 Hz, 3H), 0.99 (d, *J* = 3.5 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 141.3, 126.9, 50.8, 50.2, 32.3, 25.5, 20.5, 20.2 ppm; HRMS (ESI-orbitrap) calcd for C~8~H~14~N~3~ \[M + H\]^+^ 152.11822 found 152.11717.

### 5-Heptyl-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5i** {#sec4.6.9}

Pale yellow viscous oil; 93% yield (15.0 mg, 0.07 mmol); *R*~f~ = 0.25 (hexanes/AcOEt 1:1); IR ν~max~ = 2955, 2923, 2853, 1548, 1456, 1377, 1310, 1213, 1094, 994, 814, 723, 692 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.39 (s, 1H), 4.48 (dd, *J* = 11.4, 8.1 Hz, 1H), 3.93 (dd, *J* = 11.5, 7.6 Hz, 1H), 3.17 (sept, *J* = 7.6 Hz, 1H), 3.07 (dd, *J* = 15.6, 8.2 Hz, 1H), 2.56 (dd, *J* = 15.6, 7.2 Hz, 1H), 1.71--1.56 (m, 2H), 1.43--1.22 (m, 10H), 0.89 (t, *J* = 6.8 Hz, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 141.1, 127.0, 51.8, 43.6, 34.4, 31.7, 29.4, 29.1, 27.5, 27.3, 22.6, 14.0 ppm; HRMS (ESI-orbitrap) calcd for C~11~H~21~N~3~Na \[M + Na\]^+^ 230.16277 found 230.16119.

### 5-Cyclohexyl-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5j** {#sec4.6.10}

Pale yellow viscous oil; 86% yield (14.0 mg, 0.07 mmol); *R*~f~ = 0.24 (hexanes/AcOEt 1:1); IR ν~max~ = 2921, 2851, 1638, 1548, 1449, 1312, 1214, 1092, 978, 889, 813, 674 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.38 (s, 1H), 4.47 (dd, *J* = 11.5, 8.3 Hz, 1H), 3.98 (dd, *J* = 11.5, 8.8 Hz, 1H), 3.07--2.89 (m, 2H), 2.60 (dd, *J* = 15.4, 8.3 Hz, 1H), 1.82--1.75 (m, 3H), 1.75--1.66 (m, 2H), 1.57--1.45 (m, 1H), 1.34--1.14 (m, 3H), 1.11--0.94 (m, 2H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 141.3, 126.9, 50.2, 49.8, 42.0, 31.2, 30.7, 26.2, 25.8, 25.4 ppm. HRMS (ESI-orbitrap) calcd for C~11~H~18~N~3~ \[M + H\]^+^ 192.14952 found 192.14848.

### 3-Methyl-5-phenyl-5,6-dihydro-4*H*-pyrrolo\[1,2*c*\]\[1,2,3\]-triazole **5k** {#sec4.6.11}

Pale yellow solid; 63% yield (12.0 mg, 0.06 mmol); mp = 54--58 °C; *R*~f~ = 0.20 (hexanes/AcOEt 1:1 developed 2×); IR ν~max~ = 3086, 3061, 2956, 2924, 2863, 1603, 1590, 1496, 1455, 1387, 1337, 1315, 1282, 1208, 1160, 1101, 1081, 1030, 809, 759, 699, 630 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.40--7.34 (m, 2H), 7.34--7.28 (m, 1H), 7.27--7.21 (m, 2H), 4.79--4.66 (m, 1H), 4.40--4.25 (m, 2H), 3.29 (dd, *J* = 15.7, 8.5 Hz, 1H), 2.93 (dd, *J* = 15.7, 7.5 Hz, 1H), 2.31 (s, 3H) ppm; ^13^C NMR (126 MHz, CDCl~3~) δ 140.7, 137.8, 135.8, 129.1, 127.7, 126.8, 53.4, 48.5, 29.1, 10.6 ppm; HRMS (ESI-orbitrap) calcd for C~12~H~13~N~3~Na \[M + Na\]^+^ 222.10017 found 222.10211.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b02764](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b02764).NMR spectra (^1^H and ^13^C) of all synthesized compounds (Figures S1--S84) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b02764/suppl_file/ao8b02764_si_001.pdf))
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